Subcutaneous Drug Delivery Market CAGR of 9.7% To Reach US$ 17,445.9 Million By 2027 | Novo Nordisk A/S, Johnson & Johnson,

𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐮𝐛𝐜𝐮𝐭𝐚𝐧𝐞𝐨𝐮𝐬 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭

Global Subcutaneous Drug Delivery Market according to a recent study released by Coherent Market Insights, the market is projected to be worth US$ 9,111.6 million in 2020, with a CAGR of 9.7% over the projection period (2020-2027).

Prefilled syringes are plastic syringes of premeasured dose that are ready to use. It improves patient compliance, dosing accuracy, usability, and protection while lowering dosing errors. Healthcare practitioners are increasingly using combination devices, especially injectable drug delivery systems such as prefilled syringes, as the number of injectable biological drugs grows.

According to Fisher Clinical Service's report, "Growth and Benefits of Pre-Filled Syringes," about 13 biotechnology drugs were commercially available in 1989, rising to 210 in 2012. According to Fisher Clinical Service, the prefilled syringes market was projected to account for a quarter of all injectable drug delivery systems in 2013 which included around 35 of the 100 top-selling drugs, which were to be incorporated in the form of injection.

In April 2020, Teva Pharmaceuticals USA, Inc. dispatched the autoinjector gadget for AJOVY (fremanezumab-vfrm) injection in the U.S. market. AJOVY is shown for the preventive treatment of migraine in adults and is offered subcutaneously to the patients. Likewise, in December 2016, Becton, Dickinson and Company declared the dispatch of BD Neopak 2.25 mL prefillable glass needle, which is produced for biopharmaceutical makers zeroed in on assembling of touchy biologic medications for the therapy of ongoing sicknesses like rheumatoid joint inflammation, psoriasis, lupus, and serious asthma. The needle offers higher volume subcutaneous injections, in this manner assisting with improving security and comfort for patients.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/2933

𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐂𝐨𝐫𝐨𝐧𝐚𝐯𝐢𝐫𝐮𝐬 (𝐂𝐨𝐯𝐢𝐝-𝟏𝟗) 𝐏𝐚𝐧𝐝𝐞𝐦𝐢𝐜:

• The pandemic of COVID-19 has had a major impact on clinical trials. According to a survey conducted on April 23, 2020 by Medidata Solutions, Inc. (an American technology firm that produces and markets applications as a service for clinical trials), 63 percent of survey respondents have avoided hiring new patients for existing clinical trials, while 43 percent have delayed their studies.

• Additionally, in March 2020, the US Food and Drug Administration (FDA) issued recommendations for administering clinical testing of medicinal drugs during the COVID-19 public health emergency. On June 3, 2020, the recommendations were revised again.

• Clinical trials for the treatment of COVID-19 are being conducted by research institutes by delivering possible medicines subcutaneously.

• For example, on April 13, 2020, the University Hospital of La Princesa began a phase 2 clinical trial to assess the safety and effectiveness of Sarilumab delivered subcutaneously for the treatment of COVID-19. The research will be finished in June 2020.

• Furthermore, healthcare institutions and researchers are conducting current clinical trials using the following safety precautions:

• Patients' approval is obtained over the internet or via video calls by healthcare providers. According to a survey conducted on April 23, 2020 by Medidata Solutions, Inc., 45 percent of respondents choose virtual/telemedicine for consulting.

• Before scheduling in-person appointments, patients get a phone call to check for COVID-19 symptoms.

• Study evaluations are carried out in isolated outpatient settings.

𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/2933

In order to broaden their product offerings in the industry, key players are focusing on implementing numerous inorganic growth initiatives such as partnership alliances, and agreements. Insulet Corporation, for example, announced an agreement with a dealer in May 2019 of its Omnipod System in Finland, Italy, Norway, Sweden and other European countries.

In addition, small businesses are concentrating on the production of novel epinephrine auto injectors that are thermally stable. Manufacturers in the global subcutaneous drug delivery industry have a growth potential because currently available drugs perform well at particular temperatures. For patients suffering from anaphylaxis due to an acute allergic attack, Windgap Medical is working on a handheld kit that can blend a dry version of the drug into solution, allowing temperature consistency and a longer shelf-life of treatment.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:

Due to increased product releases and approvals, the global subcutaneous drug delivery market is projected to develop at a CAGR of 9.7% over the forecast period. For example, Becton, Dickinson and Company obtained FDA approval for the second generation BD Nano pen needle in January 2019, which is designed for more accurate subcutaneous injection in diabetic patients.

Because of the substantial rise in self-administration of medications to cure chronic disorders, the disposable segment is projected to have a larger market share in 2020.

Because of the increasing prevalence of autoimmune diseases such as multiple sclerosis and new approvals for injector implants, the auto-immune disorders segment held a higher market share among disease indications in 2018.

𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

• 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐮𝐛𝐜𝐮𝐭𝐚𝐧𝐞𝐨𝐮𝐬 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐁𝐲 𝐔𝐬𝐚𝐛𝐢𝐥𝐢𝐭𝐲:

o Disposable
o Reusable

• 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐮𝐛𝐜𝐮𝐭𝐚𝐧𝐞𝐨𝐮𝐬 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐁𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐈𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧:

o Auto-immune Disorders
o Neurological Disorders
o Oncology Disorders
o Hormonal Disorders
o Allergy & Infectious Disorders
o Ophthalmic Disorders
o Others

• 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐮𝐛𝐜𝐮𝐭𝐚𝐧𝐞𝐨𝐮𝐬 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐁𝐲 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐓𝐲𝐩𝐞:

o Prefilled Syringe
o Autoinjector
o Spring Type
o Motorized Type
o Wearable Type
o Prefilled Pen
o Disposable
o Reusable
o Vial (Syringe)
o Pump and Others

• 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐮𝐛𝐜𝐮𝐭𝐚𝐧𝐞𝐨𝐮𝐬 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐁𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥:

o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies

𝐓𝐨 𝐆𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/2933

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.